Abstract
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial on the Efficacy, Safety and Tolerability of E5501 (AKR501) In Subjects with Chronic Immune Thrombocytopenia (ITP)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have